Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-13MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 14058 units of Mineralys Therapeutics, Inc. securities around 2026-03-13, with aggregate market value of $369,225.07. The total outstanding units is 79139956.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions...
Small CapBiotechnology
2026-03-13NKTR144Wilson Mark Andrew plan to sell securities of NEKTAR THERAPEUTICS under Form 144MEDIUM
Wilson Mark Andrew filed Form 144 to notify SEC of plan to sell 78510 units of NEKTAR THERAPEUTICS securities around 2026-03-13, with aggregate market value of $5,702,966.40. The total outstanding units is 28687963.0. The amount planned to be sold represents 0.27% of total outstanding units; ...
Small CapBiotechnology
2026-03-13RVMD144Wang Xiaolin plan to sell securities of Revolution Medicines, Inc. under Form 144MEDIUM
Wang Xiaolin filed Form 144 to notify SEC of plan to sell 2282 units of Revolution Medicines, Inc. securities around 2026-03-16, with aggregate market value of $227,264.38. The total outstanding units is 198173397.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology